TrueWealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Buy |
2,530
+209
| +9% | +$23.2K | 0.08% | 182 |
|
|
2025
Q1 | $260K | Sell |
2,321
-380
| -14% | -$42.6K | 0.09% | 183 |
|
|
2024
Q4 | $249K | Sell |
2,701
-1,099
| -29% | -$102K | 0.08% | 190 |
|
|
2024
Q3 | $319K | Sell |
3,800
-1,120
| -23% | -$93.9K | 0.11% | 167 |
|
|
2024
Q2 | $338K | Buy |
4,920
+317
| +7% | +$21.7K | 0.12% | 133 |
|
|
2024
Q1 | $337K | Buy |
4,603
+293
| +7% | +$21.5K | 0.13% | 133 |
|
|
2023
Q4 | $349K | Sell |
4,310
-42
| -1% | -$3.4K | 0.14% | 123 |
|
|
2023
Q3 | $326K | Buy |
4,352
+333
| +8% | +$25K | 0.14% | 114 |
|
|
2023
Q2 | $310K | Sell |
4,019
-504
| -11% | -$38.8K | 0.13% | 125 |
|
|
2023
Q1 | $375K | Sell |
4,523
-121
| -3% | -$10K | 0.16% | 99 |
|
|
2022
Q4 | $399K | Buy |
4,644
+776
| +20% | +$66.6K | 0.17% | 98 |
|
|
2022
Q3 | $239K | Buy |
3,868
+4
| +0.1% | +$247 | 0.11% | 137 |
|
|
2022
Q2 | $239K | Buy |
+3,864
| New | +$239K | 0.11% | 144 |
|